Aspira Women's Health Files 8-K on Financials
Ticker: AWHL · Form: 8-K · Filed: Nov 14, 2024 · CIK: 926617
| Field | Detail |
|---|---|
| Company | Aspira Women'S Health INC. (AWHL) |
| Form Type | 8-K |
| Filed Date | Nov 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, company-history
TL;DR
Aspira Women's Health filed an 8-K on Nov 14, 2024, updating its financial condition.
AI Summary
Aspira Women's Health Inc. filed an 8-K on November 14, 2024, to report on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's financial status. The company was formerly known as Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems.
Why It Matters
This filing provides investors with crucial, up-to-date information on Aspira Women's Health Inc.'s financial performance and operational status.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate new material events disclosed.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Registrant
- November 14, 2024 (date) — Date of earliest event reported
- Vermillion, Inc. (company) — Former company name
- Ciphergen Biosystems Inc (company) — Former company name
- Abiotic Systems (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Aspira Women's Health Inc., and it includes Financial Statements and Exhibits.
On what date was this 8-K filing reported?
The earliest event reported in this 8-K filing was on November 14, 2024.
What is the company's state of incorporation?
Aspira Women's Health Inc. is incorporated in Delaware.
What were some of the former names of Aspira Women's Health Inc.?
Aspira Women's Health Inc. was formerly known as Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems.
What is the company's Standard Industrial Classification code?
The company's Standard Industrial Classification code is 2835, for IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES.
Filing Stats: 521 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-11-14 08:02:09
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share AWH The Nasdaq Stock Mark
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 39KB
- 0001493152-24-045354.txt ( ) — 261KB
- awh-20241114.xsd (EX-101.SCH) — 3KB
- awh-20241114_lab.xml (EX-101.LAB) — 33KB
- awh-20241114_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aspira Women's Health Inc. Date: November 14, 2024 By: /s/ John Kallassy John Kallassy, Interim Chief Financial Officer